Perpetuum

Foundation date

18-01-2018

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

PIONEERING PLANT SCIENCE.

Perpetuum is a biotech company that develops safe, sustainable plant-based therapeutics for the effective management and improvement of healthspan of people.

Our company focuses on four R&D platforms:

  • Plant cell extraction

  • Transient expression of recombinant proteins in plants

  • Dendritic nano adjuvants

  • Biopolymer scaffolds

Upcoming events

Latest news

  • Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

    Thursday January 14th 2021

  • Celyad Oncology appoints Marina Udier, Ph.D., to Board of Directors

    Tuesday January 12th 2021

  • Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study

    Tuesday January 12th 2021